• "

    About Kawin


    • 2017-04-14 Long-acting Interferon Granted Priority Review

      On April 13th, 2017, China Food and Drug Administration (CFDA) Center for Drug Evaluation (CDE) announced the fifteenth batch of candidates for new drug applications and their applicants. Among these applicants, Kawin Technology has its classification 1 p...

    • 2015-07-23Kawin Technology passes Columbia INVIMA GMP Recheck

      Five years ago, two production lines, biochemical products injection and pharmaceutical preparation has acquired INVIMA GMP certificates. During these years, Kawin Technology experienced both local and foreign GMP checks, and successfully passed China GMP...

    • 2015-07-23Kawin Technology becomes G20 Engineering Corporation

      Kawin Technology was chosen as Beijing Biochemical Spanning Development Engineering Corporation (G20). G20 Engineering is implemented as Beijing Technology project, aimed at promoting the transition of biochemical production from strategy emerging industr...

    • 2015-07-23CEO Mr. Zhou Desheng awards “Innovative Talents Promoting Project” by Technology Admini

      Innovative Talents Promoting Project is aimed at cultivating and generating genius involving scientists, technologists and Entrepreneurial talents from all over the world, and building up an innovative talents base to enhance the development of high-level...